David Larsen
Stock Analyst at BTIG
(2.77)
# 2,011
Out of 5,040 analysts
80
Total ratings
38.46%
Success rate
0.31%
Average return
Main Sectors:
Stocks Rated by David Larsen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TOI The Oncology Institute | Reiterates: Buy | $7 | $4.69 | +49.25% | 1 | Oct 21, 2025 | |
| VEEV Veeva Systems | Reiterates: Buy | $340 | $290.54 | +17.02% | 3 | Oct 17, 2025 | |
| EVH Evolent Health | Reiterates: Buy | $20 | $7.54 | +165.25% | 6 | Sep 30, 2025 | |
| CYRX Cryoport | Maintains: Buy | $10 → $15 | $10.51 | +42.72% | 4 | Sep 18, 2025 | |
| HCAT Health Catalyst | Reiterates: Neutral | n/a | $3.12 | - | 4 | Sep 5, 2025 | |
| SLP Simulations Plus | Maintains: Buy | $41 → $25 | $17.41 | +43.60% | 3 | Jul 7, 2025 | |
| DOCS Doximity | Upgrades: Buy | $80 | $66.67 | +19.99% | 2 | Jun 2, 2025 | |
| PGNY Progyny | Upgrades: Buy | $28 | $19.23 | +45.61% | 4 | Mar 31, 2025 | |
| HIMS Hims & Hers Health | Initiates: Buy | $35 | $47.78 | -26.75% | 1 | Jan 7, 2025 | |
| HQY HealthEquity | Maintains: Buy | $110 → $130 | $96.07 | +35.32% | 4 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $31 | $26.63 | +16.41% | 3 | Nov 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $290 → $260 | $221.79 | +17.23% | 2 | Nov 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $20 | $33.52 | -40.33% | 2 | Oct 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $60 → $70 | $33.20 | +110.84% | 1 | Oct 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $7 | $2.97 | +136.09% | 1 | Sep 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $11 → $7 | $1.28 | +449.02% | 4 | May 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $13 → $14 | $6.27 | +123.29% | 3 | Apr 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $8.74 | - | 2 | Apr 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $31.09 | - | 7 | Nov 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $1.00 | - | 1 | Jun 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $35 | $25.90 | +35.14% | 1 | Apr 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $8.53 | - | 3 | Nov 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $5.53 | - | 1 | Jan 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $160.45 | - | 6 | Nov 16, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $170 → $160 | $799.48 | -79.99% | 2 | May 29, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | n/a | $63.99 | - | 5 | Apr 4, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $90 → $85 | $81.13 | +4.77% | 3 | Feb 9, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $34 → $23 | $5.47 | +320.86% | 1 | Nov 2, 2017 |
The Oncology Institute
Oct 21, 2025
Reiterates: Buy
Price Target: $7
Current: $4.69
Upside: +49.25%
Veeva Systems
Oct 17, 2025
Reiterates: Buy
Price Target: $340
Current: $290.54
Upside: +17.02%
Evolent Health
Sep 30, 2025
Reiterates: Buy
Price Target: $20
Current: $7.54
Upside: +165.25%
Cryoport
Sep 18, 2025
Maintains: Buy
Price Target: $10 → $15
Current: $10.51
Upside: +42.72%
Health Catalyst
Sep 5, 2025
Reiterates: Neutral
Price Target: n/a
Current: $3.12
Upside: -
Simulations Plus
Jul 7, 2025
Maintains: Buy
Price Target: $41 → $25
Current: $17.41
Upside: +43.60%
Doximity
Jun 2, 2025
Upgrades: Buy
Price Target: $80
Current: $66.67
Upside: +19.99%
Progyny
Mar 31, 2025
Upgrades: Buy
Price Target: $28
Current: $19.23
Upside: +45.61%
Hims & Hers Health
Jan 7, 2025
Initiates: Buy
Price Target: $35
Current: $47.78
Upside: -26.75%
HealthEquity
Nov 14, 2024
Maintains: Buy
Price Target: $110 → $130
Current: $96.07
Upside: +35.32%
Nov 11, 2024
Maintains: Buy
Price Target: $30 → $31
Current: $26.63
Upside: +16.41%
Nov 1, 2024
Maintains: Buy
Price Target: $290 → $260
Current: $221.79
Upside: +17.23%
Oct 3, 2024
Maintains: Buy
Price Target: $15 → $20
Current: $33.52
Upside: -40.33%
Oct 3, 2024
Maintains: Buy
Price Target: $60 → $70
Current: $33.20
Upside: +110.84%
Sep 17, 2024
Initiates: Buy
Price Target: $7
Current: $2.97
Upside: +136.09%
May 9, 2024
Maintains: Buy
Price Target: $11 → $7
Current: $1.28
Upside: +449.02%
Apr 23, 2024
Maintains: Buy
Price Target: $13 → $14
Current: $6.27
Upside: +123.29%
Apr 1, 2024
Downgrades: Neutral
Price Target: n/a
Current: $8.74
Upside: -
Nov 3, 2023
Downgrades: Neutral
Price Target: n/a
Current: $31.09
Upside: -
Jun 24, 2022
Initiates: Neutral
Price Target: n/a
Current: $1.00
Upside: -
Apr 28, 2022
Initiates: Buy
Price Target: $35
Current: $25.90
Upside: +35.14%
Nov 22, 2021
Downgrades: Neutral
Price Target: n/a
Current: $8.53
Upside: -
Jan 7, 2021
Initiates: Neutral
Price Target: n/a
Current: $5.53
Upside: -
Nov 16, 2018
Downgrades: Market Perform
Price Target: n/a
Current: $160.45
Upside: -
May 29, 2018
Maintains: Market Perform
Price Target: $170 → $160
Current: $799.48
Upside: -79.99%
Apr 4, 2018
Upgrades: Outperform
Price Target: n/a
Current: $63.99
Upside: -
Feb 9, 2018
Maintains: Outperform
Price Target: $90 → $85
Current: $81.13
Upside: +4.77%
Nov 2, 2017
Maintains: Market Perform
Price Target: $34 → $23
Current: $5.47
Upside: +320.86%